Merus N.V.·4

Jul 11, 4:09 PM ET

Silverman Peter B. 4

4 · Merus N.V. · Filed Jul 11, 2025

Insider Transaction Report

Form 4
Period: 2025-07-09
Transactions
  • Sale

    Common Shares

    2025-07-09$55.00/sh6,695$368,2250 total
  • Sale

    Common Shares

    2025-07-10$55.00/sh16,805$924,2750 total
  • Exercise/Conversion

    Share Option (right to buy)

    2025-07-1016,8050 total
    Exercise: $18.61Exp: 2030-02-14Common Shares (16,805 underlying)
  • Exercise/Conversion

    Common Shares

    2025-07-09$18.61/sh+6,695$124,5946,695 total
  • Exercise/Conversion

    Common Shares

    2025-07-10$18.61/sh+16,805$312,74116,805 total
  • Exercise/Conversion

    Share Option (right to buy)

    2025-07-096,69516,805 total
    Exercise: $18.61Exp: 2030-02-14Common Shares (6,695 underlying)
Footnotes (6)
  • [F1]These transactions were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 20, 2025.
  • [F2]Represents the exercise price of the options originally granted on February 14, 2020.
  • [F3]Amount represents the weighted average price of shares sold, which ranged from $55.00 to $55.07. Details of individual transactions are available upon request.
  • [F4]Amount represents the weighted average price of shares sold, which ranged from $55.00 to $55.04. Details of individual transactions are available upon request.
  • [F5]The options are fully vested and exercisable.
  • [F6]Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on February 14, 2020.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4